Ice 3 Trial

Protocol: 
IRB-AAAQ7012

Cryoablation of Low Risk Breast Cancers less than 1.5 cm: An evaluation of local recurrence (Ice3 Trial)

To evaluate the efficacy of cryoablation without lumpectomy and its impact on local and distant recurrence of early stage breast cancer.

Are you Eligible? (Inclusion Criteria)

Women 65 years of age or older may be eligible

Specialty Area(s)

Trial Location

Amanda Alonso, CCRC
Columbia University
161 Fort Washington Avenue
10th Floor
New York, NY 10032
United States